| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/HYPERTENSIONAHA.108.120352 |
| P698 | PubMed publication ID | 18852383 |
| P2093 | author name string | Robert David | |
| Julio A Chirinos | |||
| Josefina Medina-Lezama | |||
| J Alexander Bralley | |||
| Edgar Muñoz-Atahualpa | |||
| Fernando Corrales-Medina | |||
| Julio Chirinos-Pacheco | |||
| Carolina Cuba-Bustinza | |||
| Humberto Zea-Díaz | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vascular disease | Q1266890 |
| P304 | page(s) | 1051-1059 | |
| P577 | publication date | 2008-10-13 | |
| P1433 | published in | Hypertension | Q5958695 |
| P1476 | title | Endogenous nitric oxide synthase inhibitors, arterial hemodynamics, and subclinical vascular disease: the PREVENCION Study | |
| P478 | volume | 52 |
| Q33580684 | ADMA/SDMA in elderly subjects with asymptomatic carotid atherosclerosis: values and site-specific association |
| Q51529434 | Association between asymmetric dimethylarginine and indices of vascular function in patients with essential hypertension. |
| Q42287888 | Association of circulating angiogenesis inhibitors and asymmetric dimethyl arginine with coronary plaque burden |
| Q37359833 | Association of plasma ADMA levels with MRI markers of vascular brain injury: Framingham offspring study |
| Q37359838 | Association of the endogenous nitric oxide synthase inhibitor ADMA with carotid artery intimal media thickness in the Framingham Heart Study offspring cohort |
| Q28075206 | Asymmetric Dimethylarginine Is a Well Established Mediating Risk Factor for Cardiovascular Morbidity and Mortality-Should Patients with Elevated Levels Be Supplemented with Citrulline? |
| Q46516924 | Asymmetric dimethylarginine and symmetric dimethylarginine prospectively relates to carotid wall thickening in black men: the SABPA study. |
| Q35622245 | Asymmetric dimethylarginine, a biomarker of cardiovascular complications in diabetes mellitus |
| Q50244544 | Effect of statin on arginine metabolites in treated HIV-infection. |
| Q35152310 | Ethnic differences in arterial wave reflections and normative equations for augmentation index. |
| Q37096680 | Heat-assisted extraction for the determination of methylarginines in serum by CE. |
| Q58127023 | Hemodynamic Patterns Identified by Impedance Cardiography Predict Mortality in the General Population: The PREVENCION Study |
| Q36480527 | Impact of ADMA, endothelial progenitor cells and traditional cardiovascular risk factors on pulse wave velocity among prediabetic individuals. |
| Q35670550 | L-Arginine and SDMA Serum Concentrations Are Associated with Subclinical Atherosclerosis in the Study of Health in Pomerania (SHIP) |
| Q36042613 | Nitric oxide synthase, ADMA, SDMA, and nitric oxide activity in the paraventricular nucleus throughout the etiology of renal wrap hypertension |
| Q37887771 | Nitric oxide: a guardian for vascular grafts? |
| Q39040850 | Novel Pathophysiological Mechanisms in Hypertension |
| Q33873245 | Optimal definitions for abdominal obesity and the metabolic syndrome in Andean Hispanics: the PREVENCION study |
| Q34167247 | Optimization of the separation of NDA-derivatized methylarginines by capillary and microchip electrophoresis. |
| Q35055325 | Prospective risk factors for increased central augmentation index in men and women |
| Q47330030 | Relation of Serum ADMA, Apelin-13 and LOX-1 Levels with Inflammatory and Echocardiographic Parameters in Hemodialysis Patients. |
| Q85167996 | Role of the nitric oxide metabolic pathway and prostanoids in the pathogenesis of endothelial dysfunction and essential hypertension in young men |
| Q58996231 | Serum Asymmetric Dimethylarginine Concentrations in Two Models of Experimentally Induced Hypertension |
| Q33940891 | The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease |
Search more.